Well I think it's a bit more complex than that, and I think that's what we're trying to get at here, right?
It _is_ more complex than that. A LOT more complex, in fact. That's why it's been driving me crazy for years when other posters are constantly saying things like: "Eating doughnuts and cake is bad for acne because they make your body produce more androgens, which makes more sebum."
I'm not necessarily saying that eating doughnuts and cake isn't bad for acne, just that the common explanation that everybody uses about (supposedly) increasing androgens is incorrect!
The Merck study you mentioned, is that for MK386, the type 1 5alpha-reductase inhibitor?
Yes indeed. They refer to it as something else in the study, but it's definitely MK386!
I have not seen a study where they tested it on acne - could you point me to it?
J Am Acad Dermatol. 2004 Mar;50(3):443-7.
"A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris."
Leyden J, Bergfeld W, Drake L, Dunlap F, Goldman MP, Gottlieb AB, Heffernan MP, Hickman JG, Hordinsky M, Jarrett M, Kang S, Lucky A, Peck G, Phillips T, Rapaport M, Roberts J, Savin R, Sawaya ME, Shalita A, Shavin J, Shaw JC, Stein L, Stewart D, Strauss J, Swinehart J, Swinyer L, Thiboutot D, Washenik K, Weinstein G, Whiting D, Pappas F, Sanchez M, Terranella L, Waldstreicher J.
University of Pennsylvania Hospital, 36th and Spruce Streets, Philadelphia, PA 19104, USA.
Abstract
Excessive sebum production is a central aspect of the pathophysiology of acne vulgaris. Sebaceous gland function is under androgen control and it is hypothesized that dihydrotestosterone is formed by the action of 5 alpha-reductase. Type I is the controlling isoenzyme. This study describes a 3-month, multicenter, randomized, placebo-controlled clinical trial with a potent, selective inhibitor of type I 5 alpha-reductase used alone and in combination with systemic minocycline. Inhibition of type I 5 alpha-reductase was not associated with clinical improvement of acne when used alone and did not enhance the clinical benefit of systemic minocycline. These results indicate the need for further work at the molecular level to better understand the action of androgens on sebaceous gland function.
Edited by bryan, 03 May 2010 - 06:09 PM.